Link between dopamine D1 and D2 receptors in rat and human striatal tissues

Synapse

Volumn 47, Issue 4, 2003, Pages 250-254

  Seeman, Philip ^a,b   Tallerico, Teresa ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antipsychotic; High affinity; Psychosis; Raclopride; Schizophrenia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; RACLOPRIDE; SODIUM ION; DOPAMINE RECEPTOR BLOCKING AGENT;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN HOMOGENATE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; FEMALE; HUMAN; MALE; MOLECULAR INTERACTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PSYCHOMOTOR ACTIVITY; PSYCHOSIS; RAT; RECEPTOR BLOCKING; SCHIZOPHRENIA; SODIUM TRANSPORT; ANIMAL; BINDING COMPETITION; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ADULT; AGED; ANIMALS; BINDING, COMPETITIVE; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; RACLOPRIDE; RATS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA;

EID: 0037443296     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10171     Document Type: Article

References (22)

1. Arnt J. 1985. Behvaioral stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Eur J Pharmacol 113:79-88.
2. Capper-Loup C, Canales JJ, Kadaba N, Graybiel AM. 2002. Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J Neurosci 22:6218-6227
3. George SR, Watanabe M, Di Paolo T, Falardeau P, Labrie F, Seeman P. 1985. The functional state of the dopamine receptor in the anterior pituitary is in the high-affinity form. Endocrinology 117:690-697.
4. Grigoriadis D, Seeman P. 1985. Complete conversion of brain D2 dopamine receptors from the high- to the low-affinity state for dopamine agonists, using sodium ions and guanine nucleotide. J Neurochem 44:1925-1935.
5. Johansson P, Levin E, Gunne L, Ellison G. 1987. Opposite effects of a D1 and D2 agonist on oral movements in rats. Eur J Pharmacol 134:83-88.
6. Kapur S, Seeman P. 2001a. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 158:360-369.
7. Kapur S, Seeman P. 2001b. Ketamine has equal affinity for NMDA receptors and the high-affinity state of the dopamine D2 receptor. Biol Psychiatry 49:954-957.
8. Murray AM, Waddington JL. 1989. The induction of grooming and vacuous chewing by a series of D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction. Eur J Pharmacol 160:377-384.
9. Needham PL, Skill MJ, Cowan A, Redfern RJ, Heal DJ. 1993. Reserpinization severs the cooperative but not the oppositional interaction between D1 and D2 receptors. Neuropharmacology 32:515-517.
10. Onali P, Olianas MC, Gessa GL. 1984. Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. Eur J Pharmacol 99:127-128.
11. Robertson GS, Robertson HA. 1986. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats. Brain Res 384:387-390.
12. Seeman P. 2002. Atypical antipsychotics: mechanism of action. Can J Psychiat 47:27-38.
13. Seeman P, Grigoriadis D. 1987. Dopamine receptors in brain and periphery. Neurochem Int 10:1-25.
14. 3H-spiperone depend on tissue concentration: analysis and examples. J. Neurochem 43:221-235.
15. Seeman P, Watanabe M, Grigoriadis D, Tedesco JL, George SR, Svensson U, Nilsson JLG, Neumeyer JL. 1985. Dopamine D2 receptor binding sites for agonists. A tetrahedral model. Mol Pharmacol 28:391-399.
16. Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C. 1989. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc Natl Acad Sci USA 86:10156-10160.
17. Seeman P, Guan H-C, Van Tol HHM. 1993. Dopamine D4 receptors elevated in schizophrenia. Nature 365:441-445.
18. Seeman P, Sunahara RK, Niznik HB. 1994. Receptor-receptor link in membranes revealed by ligand competition: example for dopamine D1 and D2 receptors. Synapse 17:62-64.
19. Stoof JC, Kebabian JW. 1981. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum. Nature 294 366-368.
20. Surmeier DJ, Reiner A, Levine MS, Ariano MA. 1993. Are neostriatal dopamine receptors co-localized? Trends Neurosci 16:299-305.
21. Vincent SL, Khan Y, Benes FM. 1995. Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex. Synapse 19:112-120.
22. Wanibuchi F, Usuda S. 1990. Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats. Psychopharmacology 102:339-342.